Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of a bisphenol A, F, and S mixture and maternal care on the brain transcriptome of rat dams and pups. | Neurotoxicology | 2022 | 36041667 | PubTator, text mining | PubMed |
| New insights into vitamin K biology with relevance to cancer. | Trends Mol Med | 2022 | 36028390 | PubTator, text mining | PubMed |
| Testicular Immunity and Its Connection with the Microbiota. Physiological and Clinical Implications in the Light of Personalized Medicine. | J Pers Med | 2022 | 36013286 | PubTator, text mining | PubMed |
| Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery. | Int J Mol Sci | 2022 | 36012423 | PubTator, text mining | PubMed |
| Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part II). | Int J Mol Sci | 2022 | 36012159 | PubTator, text mining | PubMed |
| Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities. | Cancers (Basel) | 2022 | 36011021 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy. | Cancers (Basel) | 2022 | 36010899 | PubTator, text mining | PubMed |
| Effects of Extracellular Vesicles from Osteogenic Differentiated Human BMSCs on Osteogenic and Adipogenic Differentiation Capacity of Naïve Human BMSCs. | Cells | 2022 | 36010568 | PubTator, text mining | PubMed |
| Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer's Disease. | Biomedicines | 2022 | 36009437 | PubTator, text mining | PubMed |
| Research Progress on the Role of RNA m6A Modification in Glial Cells in the Regulation of Neurological Diseases. | Biomolecules | 2022 | 36009052 | PubTator, text mining | PubMed |
| Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma. | Curr Oncol | 2022 | 36005167 | PubTator, text mining | PubMed |
| Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development. | Front Immunol | 2022 | 36003399 | PubTator, text mining | PubMed |
| DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy. | Exp Mol Med | 2022 | 35999456 | PubTator, text mining | PubMed |
| Muscle and Bone Defects in Metastatic Disease. | Curr Osteoporos Rep | 2022 | 35994202 | PubTator, text mining | PubMed |
| Potential utility of miRNAs for liquid biopsy in breast cancer. | Front Oncol | 2022 | 35992785 | PubTator, text mining | PubMed |
| Phosphatidylserine, inflammation, and central nervous system diseases. | Front Aging Neurosci | 2022 | 35992593 | PubTator, text mining | PubMed |
| The global status of research in prostate cancer bone metastasis: A bibliometric and visualized analysis. | Front Med (Lausanne) | 2022 | 35991630 | PubTator, text mining | PubMed |
| From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades. | Front Immunol | 2022 | 35990664 | PubTator, text mining | PubMed |
| MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs. | Medicine (Baltimore) | 2022 | 35984198 | PubTator, text mining | PubMed |
| SND1 confers chemoresistance to cisplatin-induced apoptosis by targeting GAS6-AKT in SKOV3 ovarian cancer cells. | Med Oncol | 2022 | 35972612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=43